article thumbnail

The Data For Weight Loss Medications Just Keeps Pouring In.

Dr. Paddy Barrett

For over 50 years, rates of those who are overweight or obese have been rising rapidly. Recent research suggested that the weight loss market was estimated to be worth $224 billion annually in 2021 and is estimated to exceed $400 billion by 2024 1. But just because we know this fact hasn’t made the impact we would have hoped for.

Obesity 79
article thumbnail

Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week

Cardiometabolic Health Congress

In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.

Obesity 97
article thumbnail

Cardiovascular Disease and Deaths On the Rise

CardiacWire

is at an all time high, with 942k cardiovascular disease-related deaths in 2022, up by 10k from 2021. While theres no one answer for a specific patient group, the AHAs biggest CVD risk culprits should be pretty familiar – obesity, smoking/tobacco use, and sedentary behavior. From 2017 to 2020, adult obesity prevalence in the U.S.

article thumbnail

Prevalence of Overweight and Obesity in the US: Key Points

American College of Cardiology

The following are key points to remember from a review on national- and state-level prevalence of overweight and obesity among children, adolescents, and adults in the United States (US), 1990–2021, and forecasts up to 2050.

Obesity 53
article thumbnail

Winning the Battle Against Atherosclerosis: Practical, Proactive Solutions

Cardiometabolic Health Congress

The RESCUE trial (2021) demonstrated that IL-6 inhibition significantly reduced high-sensitivity C-reactive protein (hs-CRP), a marker of inflammation linked to CVD events. Primordial Prevention: Building a Foundation for Lifelong Heart Health Starting prevention efforts early in life is key to reducing the lifetime burden of CVD.

article thumbnail

Demographic and Regional Trends of Cardiovascular Disease and Obesity-Related Mortality in the United States From 1999 to 2021

The American Journal of Cardiology

Publication date: Available online 5 October 2024 Source: The American Journal of Cardiology Author(s): Ishaque Hameed, Khushboo Nusrat, Adeena Jamil, Kaneez Fatima, Abdul Mannan Khan Minhas, Stephen J. Greene, Andrew J Sauer, Javed Butler, Muhammad Shahzeb Khan

article thumbnail

Abstract 4143390: HEMODYNAMIC AND CLINICAL IMPACT OF OBESITY IN GROUP 1 PULMONARY HYPERTENSION

Circulation

Clinical and hemodynamic implications of having obesity in group 1 PH remain unknown.Hypothesis. There was no difference in survival among patients with and without obesity (HR 1.15; 95% CI 0.95-1.38; Obese patients had higher RAP (12.8 ± 6.8 L/min, p< 0001) compared to non-obese group (Table 1). vs 10.4 ± 6.5

Obesity 40